GLUCOVANCE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Glucovance, and when can generic versions of Glucovance launch?

Glucovance is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in GLUCOVANCE is glyburide; metformin hydrochloride. There are twenty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the glyburide; metformin hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Glucovance

A generic version of GLUCOVANCE was approved as glyburide; metformin hydrochloride by IMPAX LABS INC on February 18^th, 2004.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for GLUCOVANCE?
What are the global sales for GLUCOVANCE?
What is Average Wholesale Price for GLUCOVANCE?

Summary for GLUCOVANCE

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	6
Clinical Trials:	7
Patent Applications:	23
Drug Prices:	Drug price information for GLUCOVANCE
What excipients (inactive ingredients) are in GLUCOVANCE?	GLUCOVANCE excipients list
DailyMed Link:	GLUCOVANCE at DailyMed

Drug patent expirations by year for GLUCOVANCE

Recent Clinical Trials for GLUCOVANCE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Texas Tech University Health Sciences Center, El Paso	Early Phase 1
Ortho Biotech Products, L.P.	Phase 4
Brigham and Women's Hospital	Phase 4

See all GLUCOVANCE clinical trials

US Patents and Regulatory Information for GLUCOVANCE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bristol Myers Squibb	GLUCOVANCE	glyburide; metformin hydrochloride	TABLET;ORAL	021178-001	Jul 31, 2000		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bristol Myers Squibb	GLUCOVANCE	glyburide; metformin hydrochloride	TABLET;ORAL	021178-002	Jul 31, 2000		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bristol Myers Squibb	GLUCOVANCE	glyburide; metformin hydrochloride	TABLET;ORAL	021178-003	Jul 31, 2000		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for GLUCOVANCE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bristol Myers Squibb	GLUCOVANCE	glyburide; metformin hydrochloride	TABLET;ORAL	021178-001	Jul 31, 2000	⤷ Sign Up	⤷ Sign Up
Bristol Myers Squibb	GLUCOVANCE	glyburide; metformin hydrochloride	TABLET;ORAL	021178-003	Jul 31, 2000	⤷ Sign Up	⤷ Sign Up
Bristol Myers Squibb	GLUCOVANCE	glyburide; metformin hydrochloride	TABLET;ORAL	021178-002	Jul 31, 2000	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for GLUCOVANCE

See the table below for patents covering GLUCOVANCE around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Russian Federation	2286788	ТВЕРДАЯ ДОЗИРОВАННАЯ ЛЕКАРСТВЕННАЯ ФОРМА ДЛЯ ОРАЛЬНОГО ВВЕДЕНИЯ, СОДЕРЖАЩАЯ КОМБИНАЦИЮ МЕТФОРМИНА ИГЛИБЕНКЛАМИДА (SOLID DOZED PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION CONTAINING COMBINATION OF METFORMIN AND GLIBENCLAMIDE)	⤷ Sign Up
Taiwan	I245632		⤷ Sign Up
China	1486698		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for GLUCOVANCE

Recent Clinical Trials for GLUCOVANCE

Make Better Decisions: Try a trial or see plans & pricing